Pulse Biosciences, Inc. has grown revenue −21% a year over three years and 25% a year over five. Revenue growth, 3-year annual rate: −21% (Medical Instruments & Supplies median +9.8%). Revenue growth, 5-year rate: +25%, growth has slowed since the five-year average. Years of annual history on file: 11, FY2015 to FY2025, as filed.

PLSEPulse Biosciences, Inc.

Healthcare

$53.80+206% 1Y

$53.80

$12.6652 weeks$55.20

Is it growing?

Watch

Operating margin narrowing (−1756.9 points). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 to watch, 2 without data

Margin direction−1756.9 points operatingSEC EDGAR · Jun 30, 2026

Trailing-twelve-month operating margin, -10298.8% now against -8541.9% a year earlier.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is PLSE growing?

Pulse Biosciences, Inc. has grown revenue −21% a year over three years and 25% a year over five.

−21%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · shrinking · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +25%
Revenue growth, 5-year rate · −21% over three · growth has slowed since the five-year average
Years of annual history on file: 11
Years of annual history on file · FY2015 to FY2025, as filed

Details›